Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Net Income towards Common Stockholders (2009 - 2026)

Icon's (ICLR) quarterly Net Income towards Common Stockholders came in at $198.4 million in Q2 2026, down 29.22% year-over-year from $280.3 million in Q2 2025, and up 31.95% quarter-over-quarter from $150.4 million in Q1 2026.

Analysis

Icon (ICLR) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Net Income towards Common Stockholders for 18 consecutive years, with $198.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 29.22% year-over-year to $198.4 million in Q2 2026; TTM through Jun 2026 was $778.1 million, a 29.28% decrease from a year earlier, with the FY2025 full-year figure at $873.4 million, down 24.88% from the prior year.
  • Net Income towards Common Stockholders was $198.4 million for Q2 2026 at Icon, up from $150.4 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $312.6 million in Q2 2024 and troughed at $139.3 million in Q1 2022.
  • A 5-year average of $234.7 million and a median of $256.1 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders surged 301.75% in 2022 and slumped 41.78% in 2026, its largest moves.
  • Over 5 years, Net Income towards Common Stockholders stood at $257.7 million in 2022, then decreased by 1.23% to $254.6 million in 2023, then grew by 10.95% to $282.4 million in 2024, then tumbled by 39.63% to $170.5 million in 2025, then rose by 16.36% to $198.4 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $198.4 million (Q2 2026), $150.4 million (Q1 2026), and $170.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 241.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 121.36 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 198.40 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -760,000.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -13.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -46.71 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -426,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -4.28 Bn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -2.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198.40 Mn
Mar 31, 2026 150.37 Mn
Dec 31, 2025 170.51 Mn
Sep 30, 2025 258.80 Mn
Jun 30, 2025 280.31 Mn
Mar 31, 2025 258.27 Mn
Dec 31, 2024 282.42 Mn
Sep 30, 2024 279.21 Mn
Jun 30, 2024 312.59 Mn
Mar 31, 2024 288.51 Mn
Dec 31, 2023 254.56 Mn
Sep 30, 2023 264.27 Mn
Jun 30, 2023 249.34 Mn
Mar 31, 2023 232.27 Mn
Dec 31, 2022 257.73 Mn
Sep 30, 2022 203.18 Mn
Jun 30, 2022 145.10 Mn
Mar 31, 2022 139.33 Mn
Dec 31, 2021 106.39 Mn
Sep 30, 2021 -100.71 Mn